Joe Biden will get the first of dose of the two-part Pfizer vaccine on TV next week
Vice President Pence will get COVID-19 vaccine at White House on Friday
Pence wants major American television networks to broadcast his inoculation
Vice president thinks it will help boost vaccine confidence among skeptics
Pence s wife, Karen, will also get shot as will Surgeon General Dr. Jerome Adams
Surveys show African Americans are wary of taking the COVID-19 vaccine
Adams, who is black, to make public appearances to urge African Americans to get vaccinated
US officials say they re actively negotiating for additional purchases of Pfizer s coronavirus vaccine after passing up a chance to lock in a contract this summer since it was still unclear how well the shots would work. Health and Human Services Secretary Alex Azar and special adviser Dr. Moncef Slaoui also told reporters Wednesday that Pfizer had been unable to commit to a firm delivery date. Azar called that the core issue. There was no immediate comment from the company, whose CEO Albert Bourla told CNN this week it is working very collaboratively with the government to deliver additional vaccine through the federal Operation Warp Speed. That s a White House-backed, taxpayer-funded effort to quickly develop coronavirus vaccines and treatments.
WATCH: Massive winter storm rolls into the Northeast khq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from khq.com Daily Mail and Mail on Sunday newspapers.
December 17, 2020 - 8:04 PM
FDA plans to OK 2nd COVID-19 vaccine after panel endorsement
WASHINGTON (AP) â The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.
FDA Commissioner Stephen Hahn said in a statement that regulators have communicated their plans to drugmaker Moderna, which co-developed the vaccine with the National Institutes of Health. The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18 years old and up.